Alberts DS - Search Results

1

Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.

Piazza GA, Rahm AL, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts DS, Pamukcu R, et al. Piazza GA, et al. Among authors: alberts ds. Cancer Res. 1995 Jul 15;55(14):3110-6. Cancer Res. 1995. PMID: 7606732

2

Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells.

Hixson LJ, Alberts DS, Krutzsch M, Einsphar J, Brendel K, Gross PH, Paranka NS, Baier M, Emerson S, Pamukcu R, et al. Hixson LJ, et al. Among authors: alberts ds. Cancer Epidemiol Biomarkers Prev. 1994 Jul-Aug;3(5):433-8. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 7920212

3

Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels.

Piazza GA, Alberts DS, Hixson LJ, Paranka NS, Li H, Finn T, Bogert C, Guillen JM, Brendel K, Gross PH, Sperl G, Ritchie J, Burt RW, Ellsworth L, Ahnen DJ, Pamukcu R. Piazza GA, et al. Among authors: alberts ds. Cancer Res. 1997 Jul 15;57(14):2909-15. Cancer Res. 1997. PMID: 9230200

4

Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?

Alberts DS, Hixson L, Ahnen D, Bogert C, Einspahr J, Paranka N, Brendel K, Gross PH, Pamukcu R, Burt RW. Alberts DS, et al. J Cell Biochem Suppl. 1995;22:18-23. doi: 10.1002/jcb.240590804. J Cell Biochem Suppl. 1995. PMID: 8538196

5

Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines.

Valcic S, Timmermann BN, Alberts DS, Wächter GA, Krutzsch M, Wymer J, Guillén JM. Valcic S, et al. Among authors: alberts ds. Anticancer Drugs. 1996 Jun;7(4):461-8. doi: 10.1097/00001813-199606000-00011. Anticancer Drugs. 1996. PMID: 8826614

6

WR-1065, the active metabolite of amifostine (Ethyol), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells.

Alberts DS, Speicher LA, Krutzsch M, Wymer J, Capizzi RL, Conlon J, Barrett A, Aickin M. Alberts DS, et al. Eur J Cancer. 1996;32A Suppl 4:S17-20. doi: 10.1016/s0959-8049(96)00313-9. Eur J Cancer. 1996. PMID: 8976817

7

1,4-disubstituted anthracene antitumor agents.

Iyengar BS, Dorr RT, Alberts DS, Sólyom AM, Krutzsch M, Remers WA. Iyengar BS, et al. Among authors: alberts ds. J Med Chem. 1997 Nov 7;40(23):3734-8. doi: 10.1021/jm970308+. J Med Chem. 1997. PMID: 9371238

8

A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancer.

Stratton SP, Alberts DS, Einspahr JG, Sagerman PM, Warneke JA, Curiel-Lewandrowski C, Myrdal PB, Karlage KL, Nickoloff BJ, Brooks C, Saboda K, Yozwiak ML, Krutzsch MF, Hu C, Lluria-Prevatt M, Dong Z, Bowden GT, Bartels PH. Stratton SP, et al. Among authors: alberts ds. Cancer Prev Res (Phila). 2010 Feb;3(2):160-9. doi: 10.1158/1940-6207.CAPR-09-0183. Epub 2010 Jan 26. Cancer Prev Res (Phila). 2010. PMID: 20103724 Free PMC article. Clinical Trial.

9

In vitro degradation of L-phenylalanine mustard (L-PAM).

Evans TL, Chang SY, Alberts DS, Sipes IG, Brendel K. Evans TL, et al. Among authors: alberts ds. Cancer Chemother Pharmacol. 1982;8(2):175-8. doi: 10.1007/BF00255479. Cancer Chemother Pharmacol. 1982. PMID: 7105381

10

Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.

Hess LM, Krutzsch MF, Guillen J, Chow HH, Einspahr J, Batta AK, Salen G, Reid ME, Earnest DL, Alberts DS. Hess LM, et al. Among authors: alberts ds. Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):861-7. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15159320 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

616 results

Search Page